Screener
Halozyme Therapeutics HALO Income Taxes Payable
Income Taxes Payable at other companies
Other financials
Where this comes from
Reported directly by Halozyme Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:TaxesPayableCurrent.
The source filing: Halozyme Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001159036-26-000104
FAQ
- What is Halozyme Therapeutics's income taxes payable?
- Halozyme Therapeutics (HALO) reported income taxes payable of $26.43M in Q2 2026.
- How has Halozyme Therapeutics's income taxes payable changed year-over-year?
- Halozyme Therapeutics's income taxes payable increased by 5.9% year-over-year, from $24.96M to $26.43M.
- What is the long-term trend for Halozyme Therapeutics's income taxes payable?
- Over 4 years (2021 to 2025), Halozyme Therapeutics's income taxes payable has grown at a 135.3% compound annual growth rate (CAGR), from $1.44M to $44.15M.
- What does income taxes payable mean?
- Current income taxes owed to federal, state, and local tax authorities for the current and prior periods.
Ask your AI about Halozyme Therapeutics's income taxes payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude